New research: low-dose aspirin regimen can cut risk of pancreatic cancer

June 26, 2014 7:24 PM

5 0

New research: low-dose aspirin regimen can cut risk of pancreatic cancer

Washington — - People on a long-term, low-dose aspirin regimen can cut their risk of pancreatic cancer nearly in half, according to a new study by researchers at Yale University.

People who took 75 mg to 325 mg of aspirin per day for six years or less reduced their risk of developing pancreatic cancer by 39 percent, according to the study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Read more

To category page

Loading...